REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 505 filers reported holding REPLIGEN CORP in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,253,977,660 | +13.8% | 7,886,156 | +1.2% | 0.04% | +20.0% |
Q2 2023 | $1,102,125,744 | -9.9% | 7,791,077 | +7.2% | 0.03% | -16.7% |
Q1 2023 | $1,223,800,247 | +18.0% | 7,268,949 | +18.7% | 0.04% | +12.5% |
Q4 2022 | $1,036,827,173 | -6.4% | 6,123,839 | +3.5% | 0.03% | -15.8% |
Q3 2022 | $1,107,536,000 | +27.4% | 5,919,189 | +10.5% | 0.04% | +35.7% |
Q2 2022 | $869,543,000 | -13.8% | 5,354,327 | -0.2% | 0.03% | +3.7% |
Q1 2022 | $1,009,173,000 | -26.6% | 5,365,357 | +3.4% | 0.03% | -22.9% |
Q4 2021 | $1,374,303,000 | -9.0% | 5,189,189 | -0.7% | 0.04% | -16.7% |
Q3 2021 | $1,509,532,000 | +42.4% | 5,223,470 | -1.7% | 0.04% | +40.0% |
Q2 2021 | $1,060,433,000 | +14.4% | 5,312,264 | +11.4% | 0.03% | +11.1% |
Q1 2021 | $926,866,000 | +6.7% | 4,767,587 | +5.2% | 0.03% | -3.6% |
Q4 2020 | $868,557,000 | +34.1% | 4,532,467 | +3.3% | 0.03% | +16.7% |
Q3 2020 | $647,539,000 | +17.2% | 4,388,903 | -1.8% | 0.02% | +9.1% |
Q2 2020 | $552,447,000 | +1.3% | 4,469,283 | -20.9% | 0.02% | -18.5% |
Q1 2020 | $545,162,000 | +2.0% | 5,647,015 | -2.3% | 0.03% | +35.0% |
Q4 2019 | $534,549,000 | +23.6% | 5,778,909 | +2.4% | 0.02% | +11.1% |
Q3 2019 | $432,604,000 | -20.7% | 5,640,911 | -11.2% | 0.02% | -21.7% |
Q2 2019 | $545,830,000 | +63.5% | 6,350,552 | +12.4% | 0.02% | +53.3% |
Q1 2019 | $333,841,000 | +13.4% | 5,650,666 | +1.2% | 0.02% | 0.0% |
Q4 2018 | $294,507,000 | -14.5% | 5,584,086 | -10.1% | 0.02% | 0.0% |
Q3 2018 | $344,558,000 | +25.2% | 6,212,759 | +6.2% | 0.02% | +15.4% |
Q2 2018 | $275,239,000 | +41.8% | 5,851,161 | +9.1% | 0.01% | +44.4% |
Q1 2018 | $194,120,000 | -0.2% | 5,365,384 | +0.1% | 0.01% | 0.0% |
Q4 2017 | $194,473,000 | -3.9% | 5,360,343 | +1.6% | 0.01% | -10.0% |
Q3 2017 | $202,272,000 | +1.0% | 5,278,485 | +9.2% | 0.01% | -9.1% |
Q2 2017 | $200,355,000 | +22.0% | 4,834,853 | +3.7% | 0.01% | +22.2% |
Q1 2017 | $164,187,000 | +162461.4% | 4,664,302 | +143196.5% | 0.01% | – |
Q4 2016 | $101,000 | -61.5% | 3,255 | -62.5% | 0.00% | – |
Q3 2016 | $262,000 | +2.3% | 8,684 | -7.0% | 0.00% | – |
Q2 2016 | $256,000 | +245.9% | 9,333 | +237.7% | 0.00% | – |
Q1 2016 | $74,000 | +60.9% | 2,764 | +70.4% | 0.00% | – |
Q4 2015 | $46,000 | +15.0% | 1,622 | +13.6% | 0.00% | – |
Q3 2015 | $40,000 | +5.3% | 1,428 | +53.9% | 0.00% | – |
Q2 2015 | $38,000 | +65.2% | 928 | +22.4% | 0.00% | – |
Q1 2015 | $23,000 | +53.3% | 758 | 0.0% | 0.00% | – |
Q4 2014 | $15,000 | 0.0% | 758 | 0.0% | 0.00% | – |
Q3 2014 | $15,000 | -11.8% | 758 | 0.0% | 0.00% | – |
Q2 2014 | $17,000 | +41.7% | 758 | -19.5% | 0.00% | – |
Q1 2014 | $12,000 | -7.7% | 942 | 0.0% | 0.00% | – |
Q4 2013 | $13,000 | +30.0% | 942 | 0.0% | 0.00% | – |
Q3 2013 | $10,000 | +25.0% | 942 | 0.0% | 0.00% | – |
Q2 2013 | $8,000 | – | 942 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |